MedCity News September 24, 2021
Frank Vinluan

Life sciences companies are using “digital twins” for everything from drug discovery to manufacturing. A panel of experts at MedCity News’ INVEST Digital Health conference discussed how this capability to run virtual simulations is changing practices now while also shaping the industry for the years to come.

Digital twins, virtual representations of objects or processes in the real world, are increasingly finding use in life sciences applications, but the example that many people use to explain the concept is an old one that comes from a different industry entirely. More than a half century ago, the astronauts of Apollo 13 were guided home with the help of simulations conducted here on Earth.

Conditions caused by a potentially catastrophic failure were...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Digital Health, Pharma / Biotech, Technology, Trends
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs
Big Pharma's ROI for drug R&D saw 'welcome' rebound in 2023: report
STAT+: Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved
STAT+: Profiting from ‘legal’ insider trading isn’t always easy
Regeneron expands in gene editing with Mammoth deal

Share This Article